Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel <i>FGFR1</i> fusion treated with pemigatinib
Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Valentina Nardi(Harvard University)
Cited by 4